Isangina

Isosorbide Mononitrate, the active ingredient in Isangina, is an organic nitrate presented as an oral tablet for oral use. It is employed to prevent and treat episodes of angina pectoris in adult patients with coronary artery disease, helping to reduce chest pain and improve exercise tolerance. GNH USA supplies Isangina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards, providing full regulatory documentation, and offering reliable logistics and import support across multiple regions.

Isosorbide Mononitrate is used in the management of coronary artery disease by relieving myocardial oxygen demand through vasodilation.

- Stable angina: reduces frequency and severity of chest pain episodes, improving patients’ ability to perform daily activities. - Chronic angina: enhances exercise tolerance by decreasing cardiac preload and afterload, allowing longer physical exertion without discomfort. - Angina prophylaxis: prevents angina attacks during physical or emotional stress, supporting long‑term symptom control.

Isosorbide mononitrate may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Headache: throbbing pain often occurring shortly after the first dose and may lessen with continued therapy. - Dizziness: light‑headed sensation, especially when standing quickly, that can be mitigated by rising slowly. - Flushing: warm sensation and reddening of the skin, usually transient and mild.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall that can cause faintness and may require medical attention. - Syncope: sudden loss of consciousness that warrants immediate evaluation. - Allergic reaction: rash, itching, swelling, or difficulty breathing indicating a possible hypersensitivity.

When prescribing isosorbide mononitrate, clinicians should consider several precautionary measures to ensure safe use.

- Cardiovascular assessment: evaluate baseline blood pressure and heart rate before initiating therapy. - Concomitant nitrate use: avoid combining with other nitrate preparations to prevent excessive vasodilation. - Phosphodiesterase‑5 inhibitors: do not co‑administer with sildenafil, tadalafil or similar agents due to risk of severe hypotension. - Renal impairment: adjust therapy and monitor closely in patients with reduced kidney function. - Store at room temperature: keep tablets in the original container, protect from moisture and excessive heat.

Isosorbide mononitrate can interact with other medicines, altering its effect or increasing adverse reactions.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilatory effect may cause profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): combined use can lead to dangerous blood pressure drops.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance blood pressure‑lowering effect, requiring dose adjustments. - Diuretics: concurrent use can increase the risk of orthostatic hypotension. - Alcohol: excessive intake may intensify dizziness and hypotensive episodes.